Partnering with Chinese biopharma companies - White Paper

Written By Jakub Majcher

In May 2025, bioCatalyst hosted a roundtable with three senior biopharma leaders to explore how to navigate partnerships with Chinese biopharma companies.

As geopolitical tensions, financial pressures, and evolving deal structures shape these relationships, the discussion provided practical insights into what’s working and what’s not.

Jakub Majcher https://biocatalystsearch.com
Next

Beyond Specialty: What Biopharma Leaders Learned Transitioning into Rare Disease - White Paper